Continued High Organic Growth for SII SII truly impressed us with its high organic growth in
SII – Impressive Growth thanks to Poland and Staff Augmentation
French IT and ER&D services vendor, SII, had an impressive growth in Q1 FY23 (corresponding to calendar Q2 22). Year-on-year organic growth reached 27.5%, despite demanding comps (Q1 FY22: +27.1%).
Alten – High Organic Growth in Q2 2022 Despite Challenging Comps
Alten enjoyed high organic growth in Q2 2022, despite challenging comps. Revenue growth was 18.9% yoy at cc/cs. The performance was strong given that Q1 2021 revenues were up +19.7%. This is the fifth consecutive quarter of ~20% organic growth.
Alten Finishes 2021 with an Indian-like Growth Rate
lten finished 2021 with an India-growth rate. For the third consecutive quarter, Alten has an organic (cc/cs) revenue growth close to 20%, reaching 23.2% in Q4. The company benefitted from favorable comps (-17.4% in Q4 2020) and HR decisions.
SII Achieves Its Highest Profits Ever
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org
Assystem Divests Assystem Care To Improve Its Growth Profile
Assystem Sells Assystem Care to Expleo to Accelerate Growth As disclosed during its H1 2021 results,
SII: Simply the Best this Quarter
II was simply the best this quarter. The France-headquartered ER&D services vendor had its revenues up 24.0% yoy (at cc/cs) in Q3 2021/Q2 FY22. SII matched Alten’s excellent performance (+24.0% at cc/cs) despite relatively demanding comps. Unlike peers, SII had limited exposure to automotive and aeronautics. In FY21, its revenues were only slightly down, by 1.5% at cc/cs. SII, therefore, managed to grow its Q2 FY22 revenues despite relatively demanding comps (-4.5%). Alten’s decline during the same quarter was 9.4% yoy.
Assytem’s Nuclear Engineering In A Soft Landing
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org
Alten, the Largest and Fastest-Growing in Q3!
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org
Assystem To Accelerate its Transformation By Selling Assets
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org
Will Alten Be A Significant Clinical Trials CRO?
ER&D services largest pure-play, Alten, has ambitions as a clinical trials contract research organization (CRO). During Q2 2021, the company completed the acquisition of Cmed. Cmed, a clinical trial CRO based in the UK. It is a small firm with EUR 20m in revenues and 180 consultants. It has specialized in oncology, immuno-oncology, cell therapy, and rare disease.
Alten: A Big Rebound in Q2
Alten impressed investors with its Q2 rebound: revenues had a big rebound (+19.7% yoy at cc/cs) to EUR 714m. We had anticipated this solid rebound: the comps were very favorable (Q2 2020 was down 18.4% yoy organically).
Modis Comes Into the Light with Akka
Modis came into the light two weeks ago when Adecco announced the acquisition of Akka. Modis is a decently large IT services firm with 2020 revenues of EUR 2,179m. It is little-profitable with an adjusted EBITA margin of 5.7% (2019: 6.3%). Like everyone, the company faced headwinds in 2020, with revenues down 9% in 2020 (2019: -3%).
SII Close to a 30% Organic Growth this Quarter
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org
Assystem: Nuclear Engineering Drives Growth in Q1
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org
Capgemini Betting on Altran To Reach its New 2025 Financial Objectives
Capgemini unveiled its new financial objectives for the 2020-2025 period, of which Altran will play a significant part. The company now targets a 7 to 9% annual revenue growth at cc and an adjusted EBIT margin of 14% by 2025. Capgemini will reach revenues in the range of EUR 22.2-24.4bn by 2025 (from an estimated pro-forma EUR 16.3bn in 2020) and EUR 3.1-3.4bn in adjusted EBIT (from EUR 1.5bn in 2020).
Nuclear Engineering Remains Promising for Assystem
Nuclear engineering remains promising for Assystem. Revenues of nuclear engineering proved slightly more resilient during 2020 (with a 4.2% revenue decline at cc/cs) than the company itself (-5.3%). In H1 2020, the activity was impacted by the lockdown in Europe, as nuclear engineering requires a higher level of onsite work than ER&D services. Revenues bounced back in H2, reaching a slight organic growth.
UPDATED: Akka Completes its Capital Increase. More Restructuring
Akka had a busy end of the year: it completed its capital increase and unveiled a
UPDATED: Atos Approaches DXC in a USD 10bn Transaction
Following a Reuters news release, European IT services vendor Atos confirmed it had submitted to the Board of DXC an unsolicited non-binding offer to acquire the firm. The offer is at a preliminary stage. Reuters estimated Atos’ offer to USD 10bn.
Alten Makes its Largest Acquisition Ever, in Digital
Alten is to make its largest acquisition, with Milan-headquartered SDG Group. SDG has revenues of EUR 76m and a headcount of 950. Its operating margin is ~10%. We estimate the price paid by Alten to ~EUR 60m.
SII Performed Very Well This Quarter. Really?
At first glance, SII performed very well during calendar Q3 2020 (corresponding to its Q2 FY21). Revenues were down by only 4.5% yoy at cc/cs. By comparison, Alten’s revenues were down by 19%! SII continued to overperform its French and European peers by a very significant margin.
Europe Has Entered its Second Lockdown. A Look at Financial Implications
Europe has now entered its second lockdown. The lockdowns have different restrictions levels and different lengths. The UK and France are running for the full month of November. Officials in the two countries have, however, warned the lockdown might last longer, until Christmas at least.
Assystem Lowers its Guidance Two Day Before a New Lockdown
Assystem announced its results two days before France back into a full lockdown. Despite a good financial performance in Q3 2020, the company changed, again, its guidance for full-year 2020.
Akka Raises EUR 200m. Share Up 40%
Akka’s share was up by almost 40% on Tuesday (October 6). The company reassured investors by raising EUR 200 at favorable terms for existing shareholders
Alten Accelerates its M&A Activity
Alten will accelerate its M&A activity in 2020. This is one of the tactical changes that the company announced during its H1 2020 results presentation. The company is also shifting its commercial effort to financial services, energy, and life science, and slightly accelerating its offshore deployment.